PPRS impact: has it kept the branded medicines bill within affordable limits?
Has the UK PPRS scheme met its five objectives?
How contributions from the updated PPRS have affected the DH budget for the NHS.
A new report from the Social Market Foundation think tank argues that the UK’s National Health Service should switch to paying for medicines based on patient outcomes.
Who could influence the makeup of the new PPRS?
Confidential discounts and the PPRS pricing system are making it more difficult to arrive at an accurate figure.
What could be the impact of proposed new ‘budget impact threshold’ for drugs?
The PPRS has now reached the half-way stage – a look at the stats so far.
